2 forms of the development of breast cancer
Gritsman, I.I.; Levshin, V.F.
Sovetskaia Meditsina 1: 42-45
1982
ISSN/ISBN: 0038-5077 PMID: 7063940 Document Number: 194617
Document emailed within 1 workday
Related Documents
Jakesz, R.; Hausmaninger, H. 1984: Adjuvant endocrine forms of therapy in breast cancer Wiener Klinische Wochenschrift 96(13): 492-499Semiglazov, V.F.; Orlov, A.A. 1983: Results of surgical treatment of the "minimal" forms of breast cancer Vestnik Khirurgii Imeni I. I. Grekova 130(3): 47-51
Sanchakova, A.V. 1972: Combined and complex treatment of diffuse-infiltrative forms of breast cancer Voprosy Onkologii 18(4): 6-10
Semiglazov, V.F. 1980: Clinical pathogenetic forms of breast cancer (new approaches to planned treatment) Khirurgiia 12: 27-31
Dittadi, R.; Meo, S.; Amoroso, B.; Gion, M. 1997: Detection of different estrogen receptor forms in breast cancer cytosol by enzyme immunoassay Cancer Research 57(6): 1066-1072
Garin, A.M.; Dmitrieva, N.V.; Vyshinskaia, G.V.; Lichintser, M.R. 1987: Rational combinations of hormonal and cytostatic agents in disseminated forms of breast cancer Voprosy Onkologii 33(11): 13-17
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Kaufmann, M.; Jonat, W.; Eiermann, W.; Maass, H.; Bastert, G. 1990: Breast saving operation and adjuvant therapy of breast cancer. Report of the National Institute of Health (NIH) consensus development conference, Washington, D.C., USA, 18-21 June 1990 Onkologie 13(5): 394-396
Zal'tsman, I.N.; Kolganova, I.P. 1978: Importance of roentgenological detection of early forms of breast cancer, during mass screening, for patients' survival Vestnik Rentgenologii i Radiologii 4: 75-82
Mel'nikov, D.N. 1972: Tinctorial and histochemical characteristics of the connective tissue in evaluating the state of certain histological forms of breast cancer Arkhiv Patologii 34(5): 35-40
Tominaga, T. 1999: Recent development of oral anti-cancer drugs for breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(3): 301-307
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Bazhenova, A.P. 1980: Development of breast cancer Khirurgiia 10: 3-8
Sattin, R W.; Rubin, G L.; Wingo, P A.; Webster, L A.; Ory, H W. 1987: Oral-Contraceptive Use and the Risk of Breast Cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development Obstetric and Gynecologic Survey 42(2): 120-121
Duda, R.B. 1995: Risk factors for the development of breast cancer Comprehensive Therapy 21(1): 29-34
Taguchi, T. 2012: The development of neoadjuvant chemotherapy in breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(6): 876-881
Pinedo, H.M. 2000: New development of treatment for locally advanced breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 272-273
Petrovanu, C.; Gălesanu, M.R.; Carasevici, E.; Sandica, T. 1975: Development and treatment of permeation nodules in cancer of the breast Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 79(2): 267-272
Denkert, C.; Schickling, O.; von Minckwitz, G. 2006: Preoperative chemotherapy in breast cancer and the development of new predictive markers Verhandlungen der Deutschen Gesellschaft für Pathologie 90: 114-123
Yamashita, T.; Iwata, K. 2009: New development in the treatment of breast cancer. II. Future anti-HER2 therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(13): 2551-2554